Have you traveled with a GLP-1 medication and found a storage solution that works well, or a lesson learned the hard way
The dysfunction of lipid peroxide clearance, the presence of redox-active iron as well as oxidation of polyunsaturated fatty acid (PUFA)-containing phospholipids are three essential features of ferroptosis
GLP-1 agonists reduce systolic blood pressure by 3-5 mmHg, improve lipid profiles, and lower progression to cardiovascular events by 26% in high-risk type 2 diabetes patientseffects that appear independent of weight reduction alone
The cumulative five-year risks of NAION and ION in diabetes patients on semaglutide were 0.065% and 0.08%, respectively
(Previously, cholesterol and its ester were separated by thin-layer chromatography)
For patients who discontinue GLP-1 medications, several evidence-based strategies can help maintain weight loss and metabolic improvements, though success rates vary considerably